APA
Atack J. R., Wong D. F., Fryer T. D., Ryan C., Sanabria S., Zhou Y., Dannals R. F., Eng W., Gibson R. E., Burns H. D., Vega J. M., Vessy L., Scott-Stevens P., Beech J. S., Baron J., Sohal B., Schrag M. L., Aigbirhio F. I., McKernan R. M. & Hargreaves R. J. (20100126). Benzodiazepine binding site occupancy by the novel GABAA receptor subtype-selective drug 7-(1,1-dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine (TPA023) in rats, primates, and humans. : The Journal of pharmacology and experimental therapeutics.
Chicago
Atack John R, Wong Dean F, Fryer Tim D, Ryan Christine, Sanabria Sandra, Zhou Yun, Dannals Robert F, Eng Wai-si, Gibson Raymond E, Burns H Donald, Vega Jose M, Vessy Laura, Scott-Stevens Paul, Beech John S, Baron Jean-Claude, Sohal Bindi, Schrag Michael L, Aigbirhio Franklin I, McKernan Ruth M and Hargreaves Richard J. 20100126. Benzodiazepine binding site occupancy by the novel GABAA receptor subtype-selective drug 7-(1,1-dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine (TPA023) in rats, primates, and humans. : The Journal of pharmacology and experimental therapeutics.
Harvard
Atack J. R., Wong D. F., Fryer T. D., Ryan C., Sanabria S., Zhou Y., Dannals R. F., Eng W., Gibson R. E., Burns H. D., Vega J. M., Vessy L., Scott-Stevens P., Beech J. S., Baron J., Sohal B., Schrag M. L., Aigbirhio F. I., McKernan R. M. and Hargreaves R. J. (20100126). Benzodiazepine binding site occupancy by the novel GABAA receptor subtype-selective drug 7-(1,1-dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine (TPA023) in rats, primates, and humans. : The Journal of pharmacology and experimental therapeutics.
MLA
Atack John R, Wong Dean F, Fryer Tim D, Ryan Christine, Sanabria Sandra, Zhou Yun, Dannals Robert F, Eng Wai-si, Gibson Raymond E, Burns H Donald, Vega Jose M, Vessy Laura, Scott-Stevens Paul, Beech John S, Baron Jean-Claude, Sohal Bindi, Schrag Michael L, Aigbirhio Franklin I, McKernan Ruth M and Hargreaves Richard J. Benzodiazepine binding site occupancy by the novel GABAA receptor subtype-selective drug 7-(1,1-dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine (TPA023) in rats, primates, and humans. : The Journal of pharmacology and experimental therapeutics. 20100126.